ALLR
ALLR
NASDAQ · Biotechnology

Allarity Therapeutics Inc

$1.55
+0.05 (+3.33%)
As of May 16, 2:28 AM ET ·
Financial Highlights (FY 2026)
Revenue
343.7K
Net Income
-12,037,335
Gross Margin
Profit Margin
-3,509.7%
Rev Growth
D/E Ratio
0.14
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 55.4% 55.4% 55.4%
Operating Margin -3,939.1% -22.3% -24.2% -22.7%
Profit Margin -3,509.7% -29.6% -25.2% -30.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 343.7K 2.19M 1.96M 2.40M
Gross Profit 1.21M 1.09M 1.33M
Operating Income -13,536,934 -487,059 -473,882 -545,220
Net Income -12,037,335 -647,190 -493,473 -738,397
Gross Margin 55.4% 55.4% 55.4%
Operating Margin -3,939.1% -22.3% -24.2% -22.7%
Profit Margin -3,509.7% -29.6% -25.2% -30.8%
Rev Growth +18.0% +10.8% +10.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.49M 1.72M 1.54M 1.78M
Total Equity 10.45M 6.23M 6.69M 6.01M
D/E Ratio 0.14 0.28 0.23 0.30
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -13,509,062 -712,204 -583,546 -705,797
Free Cash Flow -781,686 -525,232 -735,953